PAP

Persistent Asset Partners Portfolio holdings

AUM $258M
1-Year Est. Return 159.18%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+159.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$258M
AUM Growth
+$49.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
426
New
Increased
Reduced
Closed

Top Buys

1 +$9.09M
2 +$8.24M
3 +$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

1 +$9.07M
2 +$8.9M
3 +$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

1 Technology 46.48%
2 Healthcare 30.91%
3 Financials 9.41%
4 Consumer Discretionary 4.08%
5 Energy 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPRX
151
Eupraxia Pharmaceuticals
EPRX
$434M
$275K 0.11%
+37,926
SABS icon
152
SAB Biotherapeutics
SABS
$266M
$267K 0.1%
69,732
+49,942
BIOA
153
BioAge Labs
BIOA
$735M
$265K 0.1%
15,167
-57,607
MAZE
154
Maze Therapeutics
MAZE
$1.34B
$262K 0.1%
8,768
+2,163
PSIX
155
Power Solutions International
PSIX
$936M
$261K 0.1%
+4,295
ELVN icon
156
Enliven Therapeutics
ELVN
$2.16B
$259K 0.1%
+6,606
YMM icon
157
Full Truck Alliance
YMM
$9.87B
$256K 0.1%
+30,811
AYTU icon
158
AYTU BioPharma
AYTU
$22.5M
$254K 0.1%
92,897
+13,482
SE icon
159
Sea Limited
SE
$57B
$248K 0.1%
3,000
-2,000
RPRX icon
160
Royalty Pharma
RPRX
$23.9B
$248K 0.1%
5,178
-1,416
INO icon
161
Inovio Pharmaceuticals
INO
$99.6M
$247K 0.1%
142,164
TMO icon
162
Thermo Fisher Scientific
TMO
$179B
$247K 0.1%
503
+43
AZN icon
163
AstraZeneca
AZN
$275B
$244K 0.09%
+1,236
SYRE icon
164
Spyre Therapeutics
SYRE
$6.01B
$242K 0.09%
4,803
+2,557
DBVT
165
DBV Technologies
DBVT
$1.08B
$238K 0.09%
11,392
+5,373
ANL
166
Adlai Nortye
ANL
$746M
$233K 0.09%
+33,732
ZLAB icon
167
Zai Lab
ZLAB
$1.93B
$232K 0.09%
12,339
CRWV
168
CoreWeave Inc
CRWV
$65.1B
$224K 0.09%
+2,892
EDU icon
169
New Oriental
EDU
$7.51B
$224K 0.09%
3,956
-7,869
PHVS icon
170
Pharvaris
PHVS
$2.03B
$223K 0.09%
+7,904
SDRL icon
171
Seadrill
SDRL
$2.96B
$223K 0.09%
+4,961
FHTX icon
172
Foghorn Therapeutics
FHTX
$213M
$223K 0.09%
46,644
-464
AMRX icon
173
Amneal Pharmaceuticals
AMRX
$4.04B
$221K 0.09%
+17,808
EQ icon
174
Equillium
EQ
$176M
$220K 0.09%
110,117
+16,994
KTTA icon
175
Pasithea Therapeutics
KTTA
$21.6M
$216K 0.08%
290,555